- Home
- CASI vs WVVI Comparison
CASI vs WVVI Comparison
Compare CASI & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- WVVI
- Stock Information
- Founded
- CASI 1991
- WVVI 1983
- Country
- CASI China
- WVVI United States
- Employees
- CASI N/A
- WVVI N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- CASI Health Care
- WVVI Consumer Staples
- Exchange
- CASI Nasdaq
- WVVI Nasdaq
- Market Cap
- CASI 29.7M
- WVVI 29.5M
- IPO Year
- CASI 1996
- WVVI N/A
- Fundamental
- Price
- CASI $1.89
- WVVI $5.87
- Analyst Decision
- CASI Strong Buy
- WVVI
- Analyst Count
- CASI 1
- WVVI 0
- Target Price
- CASI $4.00
- WVVI N/A
- AVG Volume (30 Days)
- CASI 7.1K
- WVVI 4.8K
- Earning Date
- CASI 05-16-2025
- WVVI 05-13-2025
- Dividend Yield
- CASI N/A
- WVVI N/A
- EPS Growth
- CASI N/A
- WVVI N/A
- EPS
- CASI N/A
- WVVI N/A
- Revenue
- CASI $31,368,000.00
- WVVI $38,520,945.00
- Revenue This Year
- CASI N/A
- WVVI N/A
- Revenue Next Year
- CASI N/A
- WVVI N/A
- P/E Ratio
- CASI N/A
- WVVI N/A
- Revenue Growth
- CASI 8.39
- WVVI N/A
- 52 Week Low
- CASI $1.64
- WVVI $3.17
- 52 Week High
- CASI $7.67
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- CASI 47.25
- WVVI 48.22
- Support Level
- CASI $1.77
- WVVI $5.80
- Resistance Level
- CASI $1.98
- WVVI $5.96
- Average True Range (ATR)
- CASI 0.10
- WVVI 0.16
- MACD
- CASI 0.01
- WVVI 0.01
- Stochastic Oscillator
- CASI 54.55
- WVVI 41.97
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.